Showing results (401-410 of 603) with videos related to

Sort By:
Pageof 61
Leukemia|November 12, 2021
Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosisAlissa Visram, Celine Vachon, Linda B Baughn, et al.
American Journal of Hematology|July 6, 2019
Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosisAbdullah S Al Saleh, M Hasib Sidiqi, Surbhi Sidana, et al.
American Journal of Hematology|October 16, 2019
Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patientsAbdullah S Al Saleh, M Hasib Sidiqi, Angela Dispenzieri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 6, 2011
Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantationSandra M S Herrmann, Morie A Gertz, Mark D Stegall, et al.
Blood Advances|July 1, 2025
From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysisEli Muchtar, Angela Dispenzieri, Francis K Buadi, et al.
Ejhaem|July 18, 2022
Overall survival with oral selinexor plus low-dose dexamethasone versus real-world therapy in triple-class-refractory multiple myelomaPaul G Richardson, Sundar Jagannath, Ajai Chari, et al.
American Journal of Hematology|February 4, 2016
Clinical characteristics and outcomes in biclonal gammopathiesTrey C Mullikin, S Vincent Rajkumar, Angela Dispenzieri, et al.
American Journal of Hematology|November 23, 2013
Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapyTaxiarchis V Kourelis, Shaji K Kumar, Geetika Srivastava, et al.
Leukemia & Lymphoma|October 21, 2010
Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status reportMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
American Journal of Hematology|January 3, 2022
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcomeMarcella Kaddoura, Moritz Binder, David Dingli, et al.
Pageof 61